<DOC>
	<DOCNO>NCT01411696</DOCNO>
	<brief_summary>This retrospective data collection study evaluate efficacy , safety , re-injection interval OZURDEX速 treatment macular edema due RVO . Following informed consent , patient study visit . All data collect via chart review .</brief_summary>
	<brief_title>Retrospective Study Patients Receiving Two More OZURDEX速 Injections Retinal Vein Occlusion ( RVO )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Macular edema Received least 2 OZURDEX速 injection Received OZURDEX速 injection part clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>